Evidence map›Paper›PMID 32632259›Full record

ArticleNature ecology & evolution2020

Dysbiosis individualizes the fitness effect of antibiotic resistance in the mammalian gut.

Luís Leónidas Cardoso, Paulo Durão, Massimo Amicone, Isabel Gordo

Abstract read
PubMed Publisher
In one paragraph

Article in Nature ecology & evolution, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. mSystems · 2024
    Article
  7. Microbiota and metabolic adaptation shapebioRxiv : the preprint server for biology · 2024
    Article
  8. Intrahost evolution of the gut microbiota.Nature reviews. Microbiology · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. The Selective Advantage of theFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luís Leónidas Cardoso *Instituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID http://orcid.org/0000-0002-1393-0640
Paulo Durão *Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Massimo Amicone *Instituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID http://orcid.org/0000-0002-2221-606X
Isabel GordoInstituto Gulbenkian de Ciência, Oeiras, Portugal. igordo@igc.gulbenkian.pt.ORCID http://orcid.org/0000-0003-1622-5143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the absence of antibiotics, it is essential that antibiotic resistance has a fitness cost for microorganisms if suspending antibiotics treatment is to be a useful strategy for reducing antibiotic resistance. However, the cost of antibiotic resistance within the complex ecosystem of the mammalian gut is not well understood. Here, using mice, we show that the same antibiotic resistance mutation can reduce fitness in one host, while being neutral or even increasing fitness in other hosts. Such antagonistic pleiotropy is shaped by the microbiota because resistance in germ-free mice is consistently costly across all hosts, and the host-specific effect on antibiotic resistance is reduced in hosts with similar microbiotas. Using an eco-evolutionary model of competition for resources, we identify a general mechanism that underlies between-host variation and predicts that the dynamics of compensatory evolution of resistant bacteria should be host specific, a prediction that was supported by experimental evolution in vivo. The microbiome of each human is close to unique, and our results suggest that the short-term cost of resistances and their long-term within-host evolution are also highly personalized, a finding that may contribute to the observed variable outcome of withdrawing antibiotics to reduce resistance levels.

Indexed as

DysbiosisGastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBacteriaDrug Resistance, MicrobialHumansMiceAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.